Yazar Araması Sonucu

1

Oncolytic virus therapy using genetically engineered herpes simplex viruses Yazar: Tomoki Todo

Baskı/Yayın Bilgisi 2007

Tam Metin Erişim Tam Metin Erişim
Revisão

Favorilerime ekle

Kaydedildi:
2

ATIM-14. RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA Yazar: Tomoki Todo

Baskı/Yayın Bilgisi 2019

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
3

Oncolytic virus therapy: A new era of cancer treatment at dawn Yazar: Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo

Baskı/Yayın Bilgisi 2016

Tam Metin Erişim
Revisão

Favorilerime ekle

Kaydedildi:
4

Triple Combination of Oncolytic Herpes Simplex Virus-1 Vectors Armed with Interleukin-12, Interleukin-18, or Soluble B7-1 Results in Enhanced Antitumor Efficacy Yazar: Yasushi Ino, Yoshinaga Saeki, Hiroshi Fukuhara, Tomoki Todo

Baskı/Yayın Bilgisi 2006

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
5

Current status of clinical trials assessing oncolytic virus therapy for urological cancers Yazar: Satoru Taguchi, Hiroshi Fukuhara, Yukio Homma, Tomoki Todo

Baskı/Yayın Bilgisi 2017

Tam Metin Erişim
Revisão

Favorilerime ekle

Kaydedildi:
6

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma Yazar: Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

Baskı/Yayın Bilgisi 1999

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
7

A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma Yazar: Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu, Junji Shibahara, Minoru Tanaka

Baskı/Yayın Bilgisi 2022

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
8

Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System Yazar: Hiroshi Fukuhara, Yasushi Ino, Toshihiko Kuroda, Robert L. Martuza, Tomoki Todo

Baskı/Yayın Bilgisi 2005

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
9

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing Yazar: Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin, Paul A. Johnson

Baskı/Yayın Bilgisi 2001

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
10

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation Yazar: Kotaro Sugawara, Miwako Iwai, Hirotaka Ito, Minoru Tanaka, Yasuyuki Seto, Tomoki Todo

Baskı/Yayın Bilgisi 2021

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
11

Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein Yazar: Hiroaki Ikushima, Tomoki Todo, Yasushi Ino, Masamichi Takahashi, Nobuhito Saito, Keiji Miyazawa, Kohei Miyazono

Baskı/Yayın Bilgisi 2011

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
12

Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma Yazar: Hideto Koso, Hungtsung Yi, Paul Sheridan, Satoru Miyano, Yasushi Ino, Tomoki Todo, Sumiko Watanabe

Baskı/Yayın Bilgisi 2016

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
13

Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer Yazar: Kotaro Sugawara, Miwako Iwai, Shoh Yajima, Minoru Tanaka, Kazuyoshi Yanagihara, Yasuyuki Seto, Tomoki Todo

Baskı/Yayın Bilgisi 2020

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
14

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial Yazar: Tomoki Todo, Hirotaka Ito, Yasushi Ino, Hiroshi Ohtsu, Yasunori Ota, Junji Shibahara, Minoru Tanaka

Baskı/Yayın Bilgisi 2022

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
15

Oncolytic HSV Armed with Platelet Factor 4, an Antiangiogenic Agent, Shows Enhanced Efficacy Yazar: Ta‐Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, Toshihiko Kuroda, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin, Armin Kurtz

Baskı/Yayın Bilgisi 2006

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
16

Viral Shedding and Biodistribution of G207, a MuItimutated, Conditionally Replicating Herpes Simplex Virus Type 1, after Intracerebral Inoculation in Aotus Yazar: Tomoki Todo, Frank Feigenbaum, Samuel D. Rabkin, Fred D. Lakeman, Joseph Newsome, Paul A. Johnson, Erin Mitchell, Daniel J. Belliveau, Jeffrey M. Ostrove, Robert L. Martuza

Baskı/Yayın Bilgisi 2000

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
17

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates Yazar: William D. Hunter, Robert L. Martuza, Frank Feigenbaum, Tomoki Todo, Toshihiro Mineta, Takahito Yazaki, Masahiro Toda, Joseph Newsome, R. Craig Platenberg, Herbert J. Manz, Samuel D. Rabkin

Baskı/Yayın Bilgisi 1999

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
18

Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma Yazar: Lushun Chalise, Akira Kato, Masasuke Ohno, Sachi Maeda, Akane Yamamichi, Shunichiro Kuramitsu, Satoshi Shiina, Hiromi Takahashi, Sachiko Ozone, Junya Yamaguchi, Yukinari Kato, Yumi Rockenbach, Atsushi Natsume, Tomoki Todo

Baskı/Yayın Bilgisi 2022

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
19

<scp>SIRT</scp> 2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity Yazar: Kosuke Funato, Tomoatsu Hayashi, Kanae Echizen, Lumi Negishi, Naomi Shimizu, Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Yasuyuki Morishita, Viviane Tabar, Tomoki Todo, Yasushi Ino, Akitake Mukasa, Nobuhito Saito, Tetsu Akiyama

Baskı/Yayın Bilgisi 2018

Tam Metin Erişim Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:
20

5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex Yazar: Hiroki Takai, Koji Masuda, Tomohiro Sato, Yuriko Sakaguchi, Takeo Suzuki, Tsutomu Suzuki, Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Yuki Katou, Haruo Ogawa, Yasuyuki Morishita, Hiroko Kozuka‐Hata, Masaaki Oyama, Tomoki Todo, Yasushi Ino, Akitake Mukasa, Nobuhito Saito, Chikashi Toyoshima, Katsuhiko Shirahige, Tetsu Akiyama

Baskı/Yayın Bilgisi 2014

Tam Metin Erişim
Artigo

Favorilerime ekle

Kaydedildi:

Arama Sonuçları - Tomoki Todo

Oncolytic virus therapy using genetically engineered herpes simplex viruses Yazar: Tomoki Todo

ATIM-14. RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA Yazar: Tomoki Todo

Oncolytic virus therapy: A new era of cancer treatment at dawn Yazar: Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo

Triple Combination of Oncolytic Herpes Simplex Virus-1 Vectors Armed with Interleukin-12, Interleukin-18, or Soluble B7-1 Results in Enhanced Antitumor Efficacy Yazar: Yasushi Ino, Yoshinaga Saeki, Hiroshi Fukuhara, Tomoki Todo

Current status of clinical trials assessing oncolytic virus therapy for urological cancers Yazar: Satoru Taguchi, Hiroshi Fukuhara, Yukio Homma, Tomoki Todo

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma Yazar: Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma Yazar: Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu, Junji Shibahara, Minoru Tanaka

Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System Yazar: Hiroshi Fukuhara, Yasushi Ino, Toshihiko Kuroda, Robert L. Martuza, Tomoki Todo

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing Yazar: Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin, Paul A. Johnson

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation Yazar: Kotaro Sugawara, Miwako Iwai, Hirotaka Ito, Minoru Tanaka, Yasuyuki Seto, Tomoki Todo

Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein Yazar: Hiroaki Ikushima, Tomoki Todo, Yasushi Ino, Masamichi Takahashi, Nobuhito Saito, Keiji Miyazawa, Kohei Miyazono

Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma Yazar: Hideto Koso, Hungtsung Yi, Paul Sheridan, Satoru Miyano, Yasushi Ino, Tomoki Todo, Sumiko Watanabe

Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer Yazar: Kotaro Sugawara, Miwako Iwai, Shoh Yajima, Minoru Tanaka, Kazuyoshi Yanagihara, Yasuyuki Seto, Tomoki Todo

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial Yazar: Tomoki Todo, Hirotaka Ito, Yasushi Ino, Hiroshi Ohtsu, Yasunori Ota, Junji Shibahara, Minoru Tanaka

Oncolytic HSV Armed with Platelet Factor 4, an Antiangiogenic Agent, Shows Enhanced Efficacy Yazar: Ta‐Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, Toshihiko Kuroda, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin, Armin Kurtz

Arama Araçları:

İlgili Konular